Cargando…
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
BACKGROUND: The aims of this study were to detect HPV E6/E7 mRNA expression in women with high-risk genotypes (HPV-16, -18, -31, -33 and -45) analysing its relationship with tissue pathology and 2) 2-year follow-up of E6/E7 mRNA tested group. METHODS: Our samples were genotyped and classified by pat...
Autores principales: | Fontecha, Nerea, Basaras, Miren, Hernáez, Silvia, Andía, Daniel, Cisterna, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097850/ https://www.ncbi.nlm.nih.gov/pubmed/27816058 http://dx.doi.org/10.1186/s12885-016-2885-x |
Ejemplares similares
-
RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
por: Fontecha, Nerea, et al.
Publicado: (2017) -
Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain
por: Arroyo, L. Sara, et al.
Publicado: (2016) -
Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain
por: Arroyo, Sara L, et al.
Publicado: (2012) -
REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022) -
Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates
por: Boumba, Luc Magloire Anicet, et al.
Publicado: (2015)